Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.ferventsynergies.com | |
Market Cap | 43.20 Cr. | |
Enterprise Value(EV) | 43.20 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -0.06 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-09 |
Industry PE | 40.91 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 14.36 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 1.00 | Calculated using Price: 14.40 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 3.00 Cr. | 30,000,000 Shares |
FaceValue | 10 | |
Company Profile | ||
The company is in the business of dealing in Pharmaceutical and Chemical products, import-export, trading and distribution of various chemicals, solvents, APIs, intermediates & other bulk drugs. They are located in Mumbai, Maharashtra. |
1 Day |
|
-3.36% |
1 Week |
|
-3.10% |
1 Month |
|
+0.91% |
3 Month |
|
+3.75% |
6 Month |
|
+10.77% |
1 Year |
|
-19.78% |
2 Year |
|
+3.08% |
5 Year |
|
-35.86% |
10 Year |
|
-40.0% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 4.80 | 6.01 | 5.10 | 6.09 | 2.01 | 2.92 | 0.55 | 0.41 | -0.55 | |
Return on Capital Employed (%) | 7.37 | 9.04 | 7.73 | 8.87 | 2.77 | 4.27 | 1.07 | 0.57 | -0.46 | |
Return on Assets (%) | 4.69 | 5.84 | 4.96 | 5.91 | 1.97 | 2.88 | 0.54 | 0.40 | -0.55 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 28 | 36 | 38 | 41 | 42 | 43 | 43 | 43 | 43 | 43 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Curr. Liab. | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | |
Minority Int. | |||||||||||
Equity & Liab. | 29 | 37 | 39 | 42 | 42 | 43 | 43 | 44 | 43 | 43 | |
Non Curr. Assets | 1 | 0 | 0 | 2 | 5 | 18 | 18 | 18 | 16 | 16 | |
Curr. Assets | 28 | 37 | 39 | 40 | 38 | 25 | 25 | 25 | 27 | 27 | |
Misc. Exp. not W/O | 0 | 0 | |||||||||
Total Assets | 29 | 37 | 39 | 42 | 42 | 43 | 43 | 44 | 43 | 43 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 3 | 4 | 4 | 39 | 6 | 17 | 7 | 2 | 1 | 1 | |
Other Income | 0 | 0 | 1 | 0 | 0 | 0 | 0 | ||||
Total Income | 3 | 4 | 4 | 40 | 6 | 17 | 7 | 2 | 1 | 1 | |
Total Expenditure | -1 | -1 | -1 | -36 | -4 | -15 | -7 | -2 | -1 | -1 | |
PBIDT | 2 | 3 | 3 | 4 | 1 | 2 | 0 | 0 | 0 | 0 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Taxation | -1 | -1 | -1 | -1 | 0 | -1 | 0 | 0 | 0 | 0 | |
Exceptional Items | |||||||||||
PAT | 1 | 2 | 2 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | |
Adjusted EPS | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 3 | -4 | 1 | -6 | -2 | 3 | 12 | 2 | 0 | -2 | |
Cash Fr. Inv. | 1 | -2 | 1 | -2 | -14 | 0 | 2 | ||||
Cash Fr. Finan. | 6 | ||||||||||
Net Change | 3 | -4 | 8 | -8 | -1 | 0 | -2 | 2 | 0 | 0 | |
Cash & Cash Eqvt | 16 | 13 | 21 | 12 | 0 | 1 | -2 | 0 | 0 | 0 |
Thu, 02 Feb 2023
Financial Results For The Third Quarter Ended 31St December 2022 In terms of Regulation 30 read with Schedule III and Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 we wish to inform that the Board of Directors of the Company at its Meeting held today i.e. 2nd February 2023 inter-alia approved the following:1. Approved the Unaudited Financial results of the Company for the Third quarter ended 31st December 2022 along with limited review report thereon is enclosed herewith.The board Meeting commenced at 3.30 p.m. and concluded at 4.15 p.m. |
Tue, 17 Jan 2023
Board Meeting Intimation for Considering Unaudited Financial Results For The Quarter Ended 31St December 2022 FERVENT SYNERGIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2023 inter alia to consider and approve Unaudited Financial Results for the quarter ended 31st December 2022 |
Wed, 11 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 ln accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the Quarter ended 31st December 2022 based on the certificate received from Link Intime India Private Limited (RTA) which is enclosedherewith we hereby confirm that within 15 days of receipt of the securities received for dematerialization that:a) the securities comprised in the said Certificate(s) of security have been listed on the Stock Exchanges; andb) the said Certificate(s) after due verification have been mutilated and cancelled and the name of the depository has been substituted in our records as the registered owner. |
Thu, 02 Feb 2023 |
|
|
|
|
|